“…Mounting studies have been conducted to investigate the physiological role and mechanisms of Tph cells, predominantly focusing on autoimmune diseases (shown in Table 1), including RA (6,7,48,(52)(53)(54), SLE (26, [55][56][57][58][59][60][61], SS (62-66), IgG4-related disease (IgG4-RD) (64, 67), type 1 diabetes (T1D) (68, 69), primary biliary cirrhosis (PBC) (70), immunoglobulin A nephropathy (IgAN) (71), juvenile idiopathic arthritis (JIA) (72), autoimmune hepatitis (AIH) (73), dermatomyositis (DM) (74), celiac disease (CeD) (58), systemic sclerosis (SSc) (58), autoimmune bowel disease (IBD) (75), and psoriasis vulgaris (PV) (76). Notably, most studies elucidated altered frequencies of Tph cells and their correlation with disease activity, and they analyzed only cTph cells because of the relative difficulty in obtaining tissue samples.…”